Medication info
Kaysillin Tablets 625 mg (Amoxicillin-Potassium Clavulanate)

Kaysillin Tablets 625 mg (Amoxicillin-Potassium Clavulanate)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
KS Pharmaceutical Co., Ltd.
Appearance
White or almost white oval film-coated tablets
Packaging
40 tablets/PTP [(4 tablets/PTP*10)]
Approval status
Active

MFDS item code 201904727 · Approved 2019.07.12 · Insurance code 059000230

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/clavulanate potassium orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/clavulanate potassium per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
KS Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute bronchitis
  • chronic bronchitis
  • lobar pneumonia
  • bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
View approved original text

This medication is effective for the treatment of infections caused by various bacteria. It is used for respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It is also helpful in treating urinary tract infections such as cystitis, urethritis, and pyelonephritis. It is effective for pelvic infections and sexually transmitted diseases like gonorrhea, and is used to treat skin and soft tissue infections such as boils, abscesses, cellulitis, and wound infections. Additionally, it is utilized for the treatment of osteomyelitis and dental infections. This drug is used to improve various bacterial infections.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. In patients with renal impairment, adjust the dose appropriately according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/clavulanate potassium per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/clavulanate potassium orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/clavulanate potassium per dose. Children: Reduce the dose in the same manner.

Precautions

This drug, being a beta-lactam antibiotic, should not be administered to patients with a history of hypersensitivity to penicillin and cephalosporin. Patients with infectious mononucleosis or lymphocytic leukemia are at higher risk of rashes and should be monitored closely. Patients with a history of liver dysfunction or jaundice due to this drug or penicillin drugs should not use it. Patients with impaired liver function or moderate to severe renal impairment should use it with caution and adjust the dosage interval as drug concentration may increase. Patients with allergic tendencies or those with symptoms such as bronchial asthma or urticaria should also be cautious. Elderly patients and those in poor general health are at risk for bleeding due to vitamin K deficiency and should be monitored. This medication may cause gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain; it must be discontinued immediately if severe symptoms occur. Liver function abnormalities may also occur, particularly in men over 60, necessitating regular liver function tests. Severe skin reactions such as rashes, itching, and in severe cases, Stevens-Johnson syndrome may occur, requiring immediate consultation with a healthcare provider. Blood disorders such as leukopenia and thrombocytopenia may rarely develop, warranting blood monitoring. Central nervous system reactions including anxiety, confusion, and seizures have been reported, thus caution is needed in patients with renal impairment or those on high doses. Acute renal failure or nephritis may occur, so if symptoms of renal dysfunction appear, administration must be halted immediately. This medication can cause vitamin K deficiency symptoms, thus patients with bleeding tendencies should be cautious and those on anticoagulants should monitor coagulation status regularly. It should be avoided in the first three months of pregnancy, and pregnant or nursing women should use it cautiously after consulting a doctor. It is not recommended for children under 12 years of age or weighing less than 40 kg, as there is limited experience. Due to many drug interactions, patients should consult with a doctor or pharmacist when taking this drug with others, particularly anticoagulants, gout medication, and antibiotics. Overdose may lead to gastrointestinal symptoms, kidney issues, or central nervous system abnormalities, thus immediate medical attention should be sought.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • anorexia
Show 74 more
  • abdominal pain
  • abdominal distension
  • constipation
  • colonic pain
  • hyperacidity
  • loose stools
  • xerostomia
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • hematochezia
  • itching
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • vesicular exanthema
  • acute generalized pustular psoriasis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • vaginal burning
  • increased secretion
  • agitation
  • anxiety
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • anti-rigid therapy
  • fever
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • symptoms of vitamin B complex deficiency
  • linear IgA disease
  • dysgeusia
  • malaise
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • renal failure
  • interstitial cerebral convulsions
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent moisture and kept at a cool temperature between 1 and 25 degrees Celsius. This storage method helps maintain the effectiveness and safe use of the drug.

Appearance and packaging

Appearance

White or almost white oval film-coated tablets

Package unit

40 tablets/PTP [(4 tablets/PTP*10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.